Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
Official Summary
The goal of this observational study is to learn whether information collected during routine hospital care, together with blood and urine samples, can help doctors better identify different types of cardiogenic shock and better predict outcomes in adults hospitalized with acute heart failure and cardiogenic shock. The main question is whether clinical findings, imaging results, and biomarkers, including sex-specific factors, are associated with the risk of death within 30 days. Participants will not receive an experimental treatment. Researchers will collect data from routine care, collect additional blood and urine samples for biobanking, and follow participants after hospital discharge
Study Design
- Study Type: OBSERVATIONAL
- Enrollment: 600 participants
Primary Outcomes
- Mortality (30 days)
Secondary Outcomes
- Mortality (6 and 12 months)
- Rehospitalization for heart failure (From hospital discharge until 12 months)
- Rehospitalization for cardiac reasons (non-elective) (From hospital discharge until 12 months)
Trial Locations
- University Heart Center Freiburg - Bad Krozingen, Bad Krozingen, Germany
- University Medical Center Freiburg, Interdisciplinary Medical Intensive Care, Freiburg im Breisgau, Germany
- Department for Internal Medicine 8, Clinic for Cardiology and Rhythmology, University Clinic of the Paracelsus Medi-cal University Nuremberg, Nuremberg, Germany
- Schwarzwald Baar Klinikum Villingen-Schwenningen, Klinik für Kardiologie und Intensivmedizin, Villingen-Schwenningen, Germany
More Cardiogenic Shock Trials
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.